Myxofibrosarcoma — Trials

Myxofibrosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

20 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 8
Recruiting: 6
Ph III recruiting: 0
Growth YoY: —
Industry share: 13%
Top sponsor: Oslo University Hospital
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03425279	CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma	completed	Phase 1 / Phase 2	245	BioAtla, Inc.INDUSTRY	3	Sep 23, 2025	clinicaltrials
NCT04242238	Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas	completed	Phase 1	32	Memorial Sloan Kettering Cancer CenterOTHER	1	Aug 28, 2025	clinicaltrials